Xuhua Jiang
Shanghai Key Laboratory Of Infectious Diseases And Biosafety Emergency Response
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Methyl-CpG-binding domain protein 2 epigenetically represses monocyte HLA-DR expression and promotes immune paralysis in HBV-related acute-on-chronic liver failure.
Journal: Frontiers in immunology
Published: August 28, 2025
Circulating Cell-Free Mitochondrial DNA as a Prognostic Biomarker in Patients With HBV-Related Acute-on-Chronic Liver Failure.
Journal: Journal of medical virology
Published: March 22, 2025
Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID-19.
Journal: Fundamental & clinical pharmacology
Published: June 09, 2023
Development and Validation of a Non-invasive Model to Predict Liver Histological Lesions in Chronic Hepatitis B Patients With Persistently Normal Alanine Aminotransferase and Detectable Viremia.
Journal: Frontiers in medicine
Published: May 15, 2022
STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients receiving Peginterferon-α therapy: A prospective cohort study in China.
Journal: Journal of medical virology
Published: January 29, 2022
Baseline serum exosome-derived miRNAs predict HBeAg seroconversion in chronic hepatitis B patients treated with peginterferon.
Journal: Journal of medical virology
Published: January 25, 2021
Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
Journal: Bioscience reports
Published: August 17, 2018
Downregulation of CYP2A6 and CYP2C8 in Tumor Tissues Is Linked to Worse Overall Survival and Recurrence-Free Survival from Hepatocellular Carcinoma.
Journal: BioMed research international
Published: June 05, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026